Myotonic Dystrophy Information

open

Latest Articles

Latest Message Board Posts

Most Popular Articles

Home arrow Latest OffSite Medical News

toggle shelf

Main Menu

Home
Articles
Useful WebLinks
Contact Us
Latest OffSite Medical News
Myotonic Dystrophy Information
GuestBook
Message Boards
Detailed Search


Latest OffSite Medical News
Reuters: Health News
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.

Reuters News
  • USDA knew of problems at farm behind egg recall: report
    BANGALORE (Reuters) - U.S. Department of Agriculture experts knew about sanitary problems at one of the two Iowa farms at the center of a massive nationwide egg recall, but did not notify health authorities, the Wall Street Journal reported.


  • Study backs prostate screening for high risk men
    LONDON (Reuters) - Men who have a certain genetic variations that put them at higher risk of prostate cancer may benefit from regular screening for the disease, a study by British scientists found Friday.


  • Risks of old, new diet drugs face U.S. scrutiny
    WASHINGTON (Reuters) - The risks of a potential new diet pill and a 13-year-old weight-loss medicine face U.S. scrutiny next week as medical experts consider if the drugs' benefits outweigh possible side effects.


  • FDA cracks down on 5 makers of e-cigarettes
    CHICAGO (Reuters) - The U.S. Food and Drug Administration sent warnings to five makers of electronic cigarettes for marketing them illegally as stop-smoking aids and said on Thursday it intends to regulate the products as drugs.


  • UK's NICE wants more data on BMS schizophrenia drug
    LONDON (Reuters) - Britain's healthcare cost watchdog said it was unable to recommend use of Bristol-Myers Squibb's schizophrenia drug Abilify in children aged 15 to 17 and has asked for more information on its effectiveness.


  • J&J widens access as cancer drug helps survival
    NEW YORK (Reuters) - All patients in a study of a Johnson & Johnson drug for advanced prostate cancer will be offered the medicine after an independent monitoring committee found it demonstrated an improvement in patient survival.


  • Do kids, men need folic acid from a pill?
    NEW YORK (Reuters Health) - With the advent of folic-acid supplementation of certain foods, few Canadians are now getting too little of the B vitamin, a new study estimates -- in findings that question the need for children and men to get additional folic acid from vitamins.


  • Health reforms cause bump in spending: report
    WASHINGTON (Reuters) - Reforms will slightly accelerate the rise in healthcare spending, according to a survey released on Thursday, handing Republicans more ammunition as they attack the Obama administration's legislative victory.


  • Magnetic fields won't up kids' brain cancer risk
    NEW YORK (Reuters Health) - Exposure to extremely low-frequency magnetic fields (ELF-MFs)--emitted by anything from power lines to appliances or improperly grounded wiring--is not likely to increase children's risk of developing brain tumors, the authors of a new analysis conclude.


  • U.S. appeals court puts on hold stem cell funding ban
    WASHINGTON (Reuters) - A U.S. appeals court granted on Thursday an Obama administration request to temporarily lift a judge's ban on federal funding of research involving human embryonic stem cells.

[ Back ]

toggle shelf